Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis

Respiratory Investigation

Volumn 50, Issue 3, 2012, Pages 88-97

  Watanabe, Kentaro ^a   Nagata, Nobuhiko ^a,b   Kitasato, Yasuhiko ^c   Wakamatsu, Kentaro ^b   Nabeshima, Kazuki ^a   Harada, Taishi ^a   Hirota, Takako ^a   Shiraishi, Motokimi ^a   Fujita, Masaki ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Omuta National Hospital   (Japan)

^c FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

Author keywords

Forced vital capacity (FVC); Idiopathic interstitial pneumonia (IIP); Idiopathic pleuroparenchymal fibroelastosis; Pulmonary upper lobe fibrosis; Respiratory function

Indexed keywords

COLLAGEN; STEROID;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; ELASTIC FIBER; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HISTOLOGY; HUMAN; IDIOPATHIC PULMONARY UPPER LOBE FIBROSIS; INTERSTITIAL PNEUMONIA; MALE; MEDICAL HISTORY; ONSET AGE; PLEURA; PLEUROPARENCHYMAL FIBROELASTOSIS; PNEUMOTHORAX; PROGNOSIS; RESPIRATORY FUNCTION; RESPIRATORY TRACT PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; VITAL CAPACITY;

EID: 84875861560     PISSN: 22125345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resinv.2012.06.003     Document Type: Article

References (30)

1. Travis WD, King TE, Batemas ED, et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002, 165:277-304.
2. Davies D, Crowther JS, MacFariane A. Idiopathic progressive pulmonary fibrosis. Thorax 1975, 30:316-325.
3. Kentala E, Repo UK, Lehtipuu A-L, et al. HLA-antigen and pulmonary upper lobe fibrocystic changes with and without ankylosing spondylitis. a report of seven cases. Scand J Respir Dis 1978, 59:8-12.
4. Repo UK, Kentala E, Koistinen J. Pulmonary apical fibrocystic disease. A serology study. Eur J Respir Dis 1981, 62:46-51.
5. Fraisse P, Vandevenne FA, Ducolone A, et al. Idiopathic progressive pleuropulmonary fibrosis. Apropos of 2 cases. Rev Pneumol Clin 1984, 40:139-143.
6. Amitani R, Niimi A, Kuze F. Idiopathic pulmonary upper lobe fibrosis. Kokyu 1992, 11:693-699.
7. Kobayshi Y, Sakurai M, Kushiya M, et al. Idiopathic pulmonary fibrosis of the upper lobe: a case report. Nihon Kokyuki Gakkai Zasshi 1999, 37:812-816.
8. Kobashi Y, Ohba H, Yoneyama H, et al. A case of so-called "idiopathic pulmonary upper lobe fibrosis" complicated by both mediastinal emphysema and bilateral pneumothorax at different rimes. Kokyu 2000, 19:292-298.
9. Iwama N, Maehira N, Takahashi S, et al. A case of idiopathic pulmonary upper lobe fibrosis. Shindan Byori 2000, 17:249-251.
10. Nei T, Kawamoto M, Satoh E, et al. A case of suspected idiopathic pulmonary upper lobe fibrosis (Amitani disease) with acute exacerbation. Nihon Kokyuki Gakkai Zasshi 2009, 47:116-121.
11. Morimoto A, Mochizuki Y, Nakahara Y, et al. A case of idiopathic pulmonary upper lobe fibrosis. Nihon Kokyuki Gakkai Zasshi 2010, 48:944-948.
12. Shiota S, Shimizu K, Suzuki M, et al. Seven cases of marked pulmonary fibrosis in the upper lobe. Nihon Kokyuki Gakkai Zasshi 1999, 37:87-96.
13. Jingu K, Kawana A, Furihata K, et al. Two cases of marked pulmonary fibrosis in the upper lung field. Kokyu 1999, 18:318-323.
14. Frankel SK, Cool CD, Lynch DA, et al. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004, 126:2007-2013.
15. Becker CD, Gil J, Padilla ML Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity?. Mod Pathol 2008, 21:784-787.
16. Piciucchi S, Tomassetti S, Casoni G, et al. High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differential diagnosis. Respir Res 2011, 23:111-115.
17. Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histological and imaging phenotypes. Eur Respir J 2012;40:377-85.
18. Kaneko Y, Kikuchi N, Ishii Y, et al. Upper lobe-dominant pulmonary fibrosis showing deposits of hard metal component in the fibrotic lesions. Intern Med 2010, 49:2143-2145.
19. Japanese Respiratory Society guidelines for respiratory function tests. Medical Review Publishers: Tokyo; 2004. p. 20.
20. Foster RE, Fowler WS, Bates DV, et al. The absorption of carbon monoxide by the lungs during breath holding. J Clin Invest 1954, 33:1135-1145.
21. Comroe JH, Foster RE, Dubois AB, et al. The lung: clinical physiology and pulmonary function tests. 2nd ed. Chicago: Year Book Medical Publishers; 1973. p. 7-26.
22. Burrows B, Kasik JE, Niden AH, et al. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 1961, 84:789-806.
23. Akagi T, Matsumoto T, Harada T, et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009, 103:1209-1215.
24. Buchanan DR, Johnston IDA, Kerr IH, et al. Cryptogenic bilateral fibrosing pleuritis. Br J Dis Chest 1988, 82:186-193.
25. Hayes JP, Wiggins J, Ward K, et al. Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis): a new syndrome. Chest 1995, 107:576-578.
26. Konen E, Weisbrod GL, Pakhale S, et al. Fibrosis of the upper lobes: a newly identified late-onset complication after lung transplantation?. Am J Roentgenol 2003, 181:1539-1543.
27. von der Thusen JH, Hansell DM, Tominaga M, et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod Pathol 2011, 24:1633-1639.
28. Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989, 96:68-73.
29. Zappala CJ, Latsi PI, Nicholson AG, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010, 35:830-835.
30. Schmidt SL, Nambiar AM, Tayob N, et al. Pulmonary function measures predict mortality differently in idiopathic pulmonary fibrosis versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011, 38:176-183.